According to a recent review of clinical guideline development, the obstetric and gynecologic literature increasingly provides evidence that standardization of care not only improves patient outcomes but also ahs a positive effect on malpractice litigation.
According to a recent review of clinical guideline development, the obstetric and gynecologic literature increasingly provides evidence that standardization of care not only improves patient outcomes but also has a positive effect on malpractice litigation. Clinical practice guidelines have been developed by specialty organizations such as the American College of Obstetricians and Gynecologists, government-supported groups, hospitals or group practices, and authors of review articles.
The review cites the experience of the Hospital Corporation of America as an example of these positive effects. After an analysis of its obstetric malpractice experience showed that obstetric claims were especially high for particular drugs and procedures, the hospital network developed checklist-driven protocols (eg, for oxytocin administration) and procedure-documentation templates, coupled with mandatory online education modules. The corporation found that patient outcomes improved and that during the past 8 years, obstetric professional liability claims dropped by about half and costs for defending claims decreased fivefold.
In another example, an investigation by the RAND Institute for Civil Justice showed that in California hospitals, a decrease of 10 patient-safety-indicator adverse events in a given year was associated with a decrease of 3.7 malpractice claims. This analysis was valid for surgeons, nonsurgical physicians, and ob/gyns.
Thinner endometrial thickness linked to higher placenta accreta spectrum risk
November 29th 2024A recent study reveals that reduced endometrial thickness significantly increases the risk of placenta accreta spectrum disorders in women without prior cesarean deliveries using assisted reproductive technology.
Read More
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More
Reduced cost-effectiveness reported from HPV vaccination in mid-adults
November 27th 2024A recent study highlights the reduced cost-effectiveness of expanding human papillomavirus vaccination to adults aged 27 to 45 years compared to younger groups, though targeted strategies for high-risk subgroups indicate benefits.
Read More